tiprankstipranks
Trending News
More News >
Laboratorios Farmaceuticos Rovi, SA (ES:ROVI)
BME:ROVI
Spanish Market

Laboratorios Farmaceuticos Rovi (ROVI) Ratios

Compare
21 Followers

Laboratorios Farmaceuticos Rovi Ratios

ES:ROVI's free cash flow for Q4 2024 was €0.65. For the 2024 fiscal year, ES:ROVI's free cash flow was decreased by € and operating cash flow was €0.28. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.13 2.55 2.12 2.66 2.97
Quick Ratio
1.02 0.86 1.06 1.37 1.12
Cash Ratio
0.17 0.13 0.43 0.52 0.43
Solvency Ratio
0.66 0.76 0.62 0.67 0.40
Operating Cash Flow Ratio
0.88 0.57 0.81 0.78 0.38
Short-Term Operating Cash Flow Coverage
7.75 14.05 28.84 50.50 15.87
Net Current Asset Value
€ 239.12M€ 252.94M€ 265.75M€ 244.66M€ 163.84M
Leverage Ratios
Debt-to-Assets Ratio
0.14 0.08 0.08 0.10 0.13
Debt-to-Equity Ratio
0.20 0.12 0.14 0.16 0.20
Debt-to-Capital Ratio
0.17 0.11 0.12 0.13 0.16
Long-Term Debt-to-Capital Ratio
0.12 0.07 0.08 0.10 0.13
Financial Leverage Ratio
1.45 1.48 1.69 1.56 1.54
Debt Service Coverage Ratio
8.42 21.74 25.24 48.28 21.75
Interest Coverage Ratio
90.31 234.06 422.19 271.41 92.66
Debt to Market Cap
0.03 0.01 0.03 0.01 0.03
Interest Debt Per Share
2.27 1.28 1.36 1.33 1.34
Net Debt to EBITDA
0.42 0.16 -0.19 -0.13 0.22
Profitability Margins
Gross Profit Margin
62.63%58.27%63.55%59.32%57.46%
EBIT Margin
23.53%26.69%31.62%28.26%17.47%
EBITDA Margin
27.19%29.63%34.42%31.56%22.21%
Operating Profit Margin
23.51%26.55%31.29%27.99%17.78%
Pretax Profit Margin
23.27%26.57%31.55%28.15%17.28%
Net Profit Margin
17.92%20.53%24.42%23.60%14.54%
Continuous Operations Profit Margin
17.92%20.53%24.42%23.57%14.55%
Net Income Per EBT
77.03%77.28%77.40%83.82%84.12%
EBT Per EBIT
98.97%100.07%100.83%100.58%97.19%
Return on Assets (ROA)
16.45%21.29%22.72%20.89%10.63%
Return on Equity (ROE)
23.93%31.58%38.40%32.50%16.34%
Return on Capital Employed (ROCE)
26.58%36.71%43.75%33.48%16.54%
Return on Invested Capital (ROIC)
19.78%27.75%33.14%27.74%13.73%
Return on Tangible Assets
17.15%22.24%23.69%22.05%11.45%
Earnings Yield
4.24%5.46%10.36%3.74%2.91%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
3.29 3.22 2.41 2.71 2.82
Inventory Turnover
0.86 1.02 0.96 1.07 0.79
Fixed Asset Turnover
2.66 3.27 3.79 3.57 2.70
Asset Turnover
0.92 1.04 0.93 0.89 0.73
Working Capital Turnover Ratio
2.38 2.60 2.53 2.33 1.85
Cash Conversion Cycle
310.90 242.91 230.26 204.82 334.55
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
421.98 356.36 381.97 339.57 464.19
Days of Payables Outstanding
111.07 113.45 151.71 134.75 129.64
Operating Cycle
421.98 356.36 381.97 339.57 464.19
Cash Flow Ratios
Operating Cash Flow Per Share
2.70 2.19 4.44 2.70 0.85
Free Cash Flow Per Share
1.48 1.12 3.48 1.96 0.13
CapEx Per Share
1.21 1.06 0.96 0.74 0.72
Free Cash Flow to Operating Cash Flow
0.55 0.51 0.78 0.73 0.15
Dividend Paid and CapEx Coverage Ratio
1.17 0.91 2.32 2.41 0.95
Capital Expenditure Coverage Ratio
2.22 2.05 4.62 3.65 1.18
Operating Cash Flow Coverage Ratio
1.21 1.73 3.29 2.04 0.64
Operating Cash Flow to Sales Ratio
0.18 0.14 0.29 0.23 0.11
Free Cash Flow Yield
2.36%1.86%9.66%2.65%0.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
23.58 18.31 9.66 26.71 34.38
Price-to-Sales (P/S) Ratio
4.23 3.76 2.36 6.30 5.00
Price-to-Book (P/B) Ratio
5.64 5.78 3.71 8.68 5.62
Price-to-Free Cash Flow (P/FCF) Ratio
42.43 53.73 10.35 37.68 292.20
Price-to-Operating Cash Flow Ratio
23.34 27.55 8.11 27.36 44.78
Price-to-Earnings Growth (PEG) Ratio
-1.25 -1.55 0.27 0.18 0.63
Price-to-Fair Value
5.64 5.78 3.71 8.68 5.62
Enterprise Value Multiple
15.96 12.85 6.66 19.85 22.72
EV to EBITDA
15.96 12.85 6.66 19.85 22.72
EV to Sales
4.34 3.81 2.29 6.26 5.05
EV to Free Cash Flow
43.58 54.42 10.07 37.45 295.03
EV to Operating Cash Flow
23.97 27.90 7.89 27.19 45.21
Tangible Book Value Per Share
10.68 9.83 9.08 7.80 6.00
Shareholders’ Equity Per Share
11.16 10.41 9.73 8.50 6.75
Tax and Other Ratios
Effective Tax Rate
0.23 0.23 0.23 0.16 0.16
Revenue Per Share
14.90 16.01 15.29 11.71 7.58
Net Income Per Share
2.67 3.29 3.73 2.76 1.10
Tax Burden
0.77 0.77 0.77 0.84 0.84
Interest Burden
0.99 1.00 1.00 1.00 0.99
Research & Development to Revenue
0.00 0.00 0.03 0.04 0.06
SG&A to Revenue
0.02 0.15 0.02 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 <0.01 0.00
Income Quality
0.78 0.51 0.92 0.82 0.65
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis